Dysregulation of the host immune components may result in an abnormal response to normal commensal organisms and pathological inflammation. Early GWAS identified susceptibility loci associated with several genes involved in immune regulation and signaling, and gave further credence to existing theories about IBD pathogenesis.
Introduction
Inflammatory bowel disease (IBD) is a group of chronic and debilitating conditions characterized by inflammation of the gastrointestinal tract. Crohn's disease and ulcerative colitis are two major types of IBD that share distinct but also overlapping clinical and pathological features. Both forms are characterized by damage to the mucosa that forms the barrier to intestinal luminal contents.
In this review, we will discuss the recent studies that focus on triggers for IBD. On the basis of several decades of studies in both humans and mouse models, one major thesis that has been developed is that IBD arises in a genetically susceptible background and involves an aberrant interaction at the interface between the commensal gut microbiota (including viruses) and the host. We will discuss the effects of host genetic mutations that elevate risk for IBD, as well as the impact of the intestinal microbiota on the host. We will identify the major gaps in our knowledge and the modes of study that need to be pursued to further test this idea.
Role of genetics
We have known for the past half-century that host genetics play a key role in IBD pathogenesis [1, 2] . More recently, genome-wide association studies (GWASs) identified approximately 99 single-nucleotide polymorphisms (SNPs) that confer greater risk for ulcerative colitis and Crohn's disease. The genes associated with these SNPs provide an important starting point to discover key proteins and pathways that are involved in IBD pathogenesis. The caveat is that most of these risk alleles are present at high frequency in the target populations, but confer only modest increase in risk of the development of disease. This predicts that phenotypes associated with risk alleles will be triggered by environmental factors.
In the last year, extensive meta-analysis of the GWAS has increased the number of susceptibility alleles for both ulcerative colitis and Crohn's disease to 47 and 71, respectively [3 -5 ] . Interestingly, at least 28 of these alleles are shared between ulcerative colitis and Crohn's disease, suggesting the intriguing possibility that different environmental factors might trigger different forms of the disease. Studies of the common group of loci will be important to understand the basic pathogenesis of IBD.
For example, the involvement of the IL-23/IL-12 pathway was reinforced by recent GWAS findings. IL-23 is thought to contribute to the function of Th17 cells, which produce a variety of proinflammatory cytokines and act as a link between the innate and adaptive immune systems. Genes implicated in this pathway that are also found within IBD susceptibility loci include IL23R, TYK2, STAT3, IL12, and JAK2. However, the exact role of IL-23 and Th17 cells in intestinal inflammation is still undefined.
The most recent meta-analyses identified additional immune regulatory genes linked to IBD susceptibility loci. Genes encoding multiple cytokines and their receptors were added to the list: IL10, which is implicated in both Crohn's disease and ulcerative colitis and encodes an anti-inflammatory cytokine; RANKL, whose protein product stimulates dendritic cells, leading to T cell proliferation and regulatory T cell induction; IL8RA, encoding a receptor for the neutrophil chemotactic factor IL-8; IL7R, implicated in the regulation of the transition between effector and memory T cell development; and IL2RA, which encodes part of the high-affinity IL-2 receptor, important in T cell activation and proliferation. Key transcription factors identified include PRDM1, the master transcriptional regulator of plasma cells, and IRF5, which regulates the transcription of type I interferons and other cytokines. The identification of these additional genes supports the idea that alterations in immune signaling provide a basis for susceptibility for IBD.
Genes in host-microbe interactions
GWAS also linked risk loci with genes involved in the interaction between the host and commensal microorganisms. One of the first genes implicated in Crohn's disease susceptibility was NOD2, a cytosolic pattern recognition receptor that has the genetic variants most strongly associated with Crohn's disease. In addition, multiple genes involved in autophagic clearance of bacteria have also been implicated by GWAS, such as IRGM, ATG16L1, and ULK1 [4 ,6-10]. The mechanisms of these interactions will be discussed later in this review. MUC19 has also been associated with susceptibility loci for IBD. It encodes important components of the mucus that lines the gastrointestinal tract as a barrier defense against bacteria. A recent addition to the Crohn's disease susceptibility gene list is FUT2, which encodes an enzyme that allows for the secretion of Lewis ABO antigens on mucosal surfaces. Interestingly, alterations in this gene that prevent ABO secretion result in protection against many types of enteric norovirus infection [11, 12] . As will be discussed further in this review, viruses, including norovirus, could be a trigger for IBD.
Challenges in determining genetic susceptibility
Despite the ability of GWAS and their meta-analysis to identify genes with large single-effect, as much as 80% of the heritability of IBD may still be unidentified [13] . This 'heritability gap' may arise from multiple factors: there may be more variants with smaller effect that do not meet the stringent requirements for significance in GWASs and thus have not yet been identified; there may be rare variants that have a potentially large effect but are not included on existing genotyping arrays; and there could be gene interactions and pathways that are not captured in current approaches that focus on discovering the most significant individual SNPs.
Although it is tempting to focus on systematically filling in the heritability gap, we must consider the end goal of identifying these disease-associated variants. The objective is ultimately to improve understanding of disease pathogenesis in order to develop better methods for prevention, diagnosis, and treatment. Thus, a valuable endeavor is to try to discover gene interactions and pathways that contain gene variants that have moderate levels of significance (and are thus not identified as top SNP hits), but that are genuinely associated with the disease. Some groups have already begun to conduct pathway analysis of GWAS, including those for Crohn's disease [14, 15 ] . One group successfully uncovered significant association between Crohn's disease and the IL-12/IL-23 pathway [16] , but they identified additional genes in the pathway that did not reach significance by single-marker association tests in any previous studies. The implications of this work are that there are likely other genes and pathways that have yet to be detected by conventional methods of GWAS analysis. These could then provide novel targets for therapeutic intervention or for further studies in association with manipulation of the commensal microbial environment.
Commensal microbes as potential triggers
In addition to investigating the genetic background of an individual, substantial efforts have been dedicated to examining the role of pathogenic or commensal microbiota in triggering IBD. However, our understanding of 322 Inflammatory bowel disease
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the microbial factors contributing to disease remains limited, mostly because the biology of the commensal microbiota is poorly understood.
A 'balanced' commensal microbiota?
An emerging consensus hypothesis is that an intestinal dysbiosis (microbial imbalance) can be a trigger for IBD. Although this term has been extensively used since it was first proposed by Haenel [17] more than four decades ago, the biological basis of this 'microbial imbalance' remains poorly defined. To begin with, what constitutes a 'balanced' commensal microbiota has not been established.
The intestinal microbiota is vast and quite diverse at the species level. Current data regarding species diversity suggest that the intestinal microbiota is host-specific [18,19 ,20,21] . Under these terms, classification of 'normal' microbiota is challenging because each individual possesses a unique collection of microbial species. Therefore, to communicate alterations in the microbiome, one method has been to classify microbes based on 16S rRNA gene sequencing into two major groups: Firmicutes and Bacteroidetes, the two most predominant bacterial phyla inhabiting the intestinal tract [20, 21] . This has utility in showing gross differences in microbiota composition. However, phyla represent the highest taxonomic rank in bacterial classification, and they are composed of numerous orders, classes, families, and genera with diverse and broad metabolic, ecological, pathogenic, and symbiotic properties. Thus, description of phylum profiles possesses only limited biological relevance for understanding hostmicrobe interactions. (Remember, we as humans are classified as chordates, along with sea squirts.) A challenge then is how to determine what level of taxonomic resolution will be required to test the dysbiosis hypothesis.
Thus, the description of a 'balanced' intestinal microbiota is far from accomplished. Encouragingly, some studies have tried to resolve these issues by examining predominant genetic branches. These analyses identified a 'phylogenetic core' of bacterial species found in a large proportion of human fecal samples [19 ] . Together, these data highlight the need for novel methodologies to improve our understanding of the biology of the intestinal microbiota.
Dysbiosis and inflammatory bowel disease
A widespread idea is that dysbiosis in IBD patients stems from an increase in specific microbial populations, whereas others are decreased [22, 23] . However, the current data have not revealed reproducible alterations in microbial populations in IBD. The lack of consensus could be attributed to technical disparities including sample source (intestinal biopsies vs. stool samples) and the type of analysis of microbial changes (comprehensive vs. narrow molecular screening).
For example, evidence for dysbiosis in IBD patients has been shown in studies that analyzed stool samples [24] [25] [26] [27] , but it is well accepted that microbial populations from stool differ from those associated with the mucosa. Mucosa-associated bacteria may have more physiological relevance in IBD, as these communities are thought to be stable and in actual physical association with the host epithelium [28] [29] [30] . Thus, numerous studies have examined mucosa-associated microbial diversity in healthy and affected intestinal biopsies. However, results from these studies are not reproducible, and in some cases they are contradictory. As an example, some reports indicate reduced bacterial diversity, as well as a reduction in Firmicutes phylum with an enrichment in Bacteroidetes phylum, in ulcerative colitis and Crohn's disease patients [31 ] . In contrast, analysis of colonic biopsies from Crohn's disease patients revealed an increased prevalence of Clostridium spp., Ruminococcus torques (both members of the Firmicutes phylum), and Escherichia coli (Enterobacteriaceae family) [32] . Still more studies have reported no differences in microbial diversity in biopsy samples from control and IBD patients [29] , or in the comparison of ulcerated and nonulcerated mucosal samples from patients with IBD [33] [34] [35] .
A promising strategy to address these inconsistencies and uncover microbial alterations linked with IBD is the use of comprehensive molecular analyses of mucosa-associated microbiota. The goal of these studies is to examine microbial changes in a large set of samples using deep sequencing. Thus far, one comprehensive study by Frank et al. [22] has provided notable insights into the microbial alterations occurring in IBD. Specifically, members of the Lachnospiraceae family (Firmicutes phylum) and Bacteroidales (bacterial order) were depleted in a subset of IBD samples [22] . More importantly, this study confirmed that Faecalibacterium prausnitzii, a member of the Lachnospiraceae family, was reduced in the mucosa of IBD patients [32] .
Another interesting strategy to factor in genetic variability is to study twin cohorts. Willing et al. [34] analyzed the microbiota of 38 twin pairs that were either concordant or discordant for Crohn's disease and ulcerative colitis, along with two healthy twin pairs, and identified bacterial species that were enriched and diminished in Crohn's disease. However, even within their healthy twin pairs, the gut microbiota was similar at the genus level but differed at the species level.
In summary, these studies emphasize the importance of new methodologies for the characterization and categorization of microbial populations to first understand the biology of the intestinal microbiota, and then to reveal their contribution to IBD.
Viruses as potential triggers of inflammatory bowel disease
It is becoming increasingly clear that enteric viruses may also play a role in IBD. Viruses may act directly on the host epithelium and immune system to induce inflammation, or may alter luminal bacterial composition that then provokes disease.
For example, a recent study by Cadwell et al. [36] showed intestinal abnormalities reminiscent of human Crohn's disease and heightened inflammatory response to dextran sodium sulfate (DSS) in ATG16L1 hypomorphic mice, but only when in conjunction with infection by murine norovirus (MNV). This is a ubiquitous virus that does not normally cause disease in immunocompetent mice.
We may need to consider viruses, in addition to bacteria, as part of our commensal microbiome. It has been suggested that every individual harbors approximately eight to 12 chronic viral infections at any given time [37] , and these may be harmful only in the limited percentage of the population that has a certain genetic predisposition. Furthermore, Reyes et al. discovered that each individual has a unique fecal virome that is stable over a 1-year period. Interestingly, although related individuals shared high similarity in fecal bacterial composition, fecal viromes varied greatly between individuals independent of relatedness, and may thus act as an environmental factor in disease pathogenesis. Notably, more than 75% of the sequences did not match to any currently known viruses, an indication of how much knowledge is yet to be gained about the viral metagenome.
These chronic viral infections could have a negative impact on IBD. The involvement of cytomegalovirus (CMV) in IBD pathogenesis or exacerbation has long been a subject of debate. CMV is found in up to 79% of IBD patients [38] . After initial infection, it can remain latent and asymptomatic until reactivated under conditions of stress or immunosuppression, where it induces a colitic disease that displays some symptoms of IBD. The question is whether CMV reactivation actively worsens disease or whether reactivation is simply a bystander elicited by inflammation. A recent report by Kim et al. [39] showed that colonic CMV reactivation was rare in patients with mild-to-moderate IBD, and lack of treatment for CMV did not adversely affect the disease outcome in this subset of patients. However, the current recommendation is that patients with more severe, steroid-refractory disease should be treated for CMV reactivation if present [38] .
Pathways at the intersection of host and microbe
There are a variety of mechanisms by which the commensal microbes in the lumen of the intestine can inter-act with and influence the host epithelium and immune cells. We will discuss new evidence surrounding three main pathways -Toll-like receptor (TLR) signaling, the autophagy pathway, and the induction of regulatory T cell populations.
Toll-like receptor signaling: the role of the negative regulator IRAK-M TLRs are a family of innate immunity pattern recognition receptors that recognize components specific for microbes. In the intestine, ligation of TLRs on intestinal epithelial cells stimulates cellular proliferation, IgA production, and secretion of antimicrobial peptides, all contributing to the maintenance of intestinal homeostasis and an intact epithelial barrier [40] . Multiple groups have observed altered expression of TLRs on intestinal epithelial cells and lamina propria immune cells of patients with active IBD [41] [42] [43] . Because TLRs act to trigger an immune response, excessive activation of TLR signaling could be expected to give rise to inadequately controlled inflammation. In addition, mice lacking TLR5 have an altered intestinal microbiota [44 ] , which may impact the development of IBD.
Recently, two groups demonstrated that loss of IRAK-M, a negative regulator of TLR signaling, worsens mouse models of IBD [45, 46] . IRAK-M-deficient cells overproduce proinflammatory cytokines, with increased NF-kB and MAPK signaling [47] . Mice with a deficiency in both IL-10 and IRAK-M develop inflammation of the gut at a younger age than mice lacking IL-10 alone [45] . IRAK-M-deficient mice also have a greater loss in body weight and worse intestinal inflammation in response to DSS [46] . Notably, germ-free mice have diminished expression of IRAK-M in the colon, but colonization with commensal bacteria is able to induce IRAK-M expression in an age-dependent manner [45] . Thus, not only the TLRs themselves but also their regulators are impacted by luminal microbes, and this interaction affects intestinal homeostasis and damage responses.
One central question that persists is how to define the line between beneficial and detrimental TLR signaling in the intestinal epithelium. It is clear that some TLR ligation by commensal bacteria contributes to intestinal homeostasis, but whether specific bacterial or viral types or combinations are required, or how this process is dysregulated in disease, remain unanswered.
Autophagy: a link between NOD2 and autophagic clearance of intracellular microbes
GWASs and follow-up studies have identified multiple susceptibility loci within genes involved in the autophagy pathway, including ATG16L1, IRGM, and, most recently, ULK1 [4 ,7-10]. Autophagy is a cellular process by which cytosolic components are enveloped by a double membrane, which then fuses with the lysosome for degradation of its contents. Autophagy is a principal mechanism for the recycling of whole organelles and proteins, and is also important for the clearance of intracellular pathogens. Deficiencies in ATG16L1 and IRGM or their murine homologs (Atg16L1 and Irgm1, respectively) result in diminished ability to clear Salmonella and E. coli [10, 48, 49] , and for IRGM and Irgm1 only, mycobacteria, Listeria monocytogenes, and Toxoplasma gondii [50] [51] [52] . The functional consequences of loss of Ulk1 have not yet been demonstrated. It is conceivable that defects in the elimination of intracellular pathogens may result in dysregulated immune responses and inflammation. However, as neither mice deficient in Irgm1 nor Atg16L1 spontaneously develop colitic disease, there are certainly other contributing factors, such as viral infection and toxic insult, as shown by Cadwell et al. [36] .
In addition, studies in the last year have linked NOD2, whose variants account for the greatest known contributions to heritability in Crohn's disease, to the autophagy pathway. NOD2 is an intracellular pattern recognition receptor that binds to bacterial cell wall components and signals to produce proinflammatory cytokines and antimicrobial peptides. Studies showed that NOD2 stimulation induces autophagy, seemingly by recruiting ATG16L1 to the site of bacterial entry at the plasma membrane [53 -55 ] . This process is required for the effective clearance of intracellular Shigella and Salmonella infection in multiple cell types, including mouse embryonic fibroblasts, primary macrophages, and dendritic cells [53 -55 ] . Interestingly, the most common variant of NOD2 associated with Crohn's disease failed to recruit ATG16L1 to the plasma membrane [54 ] , and cells with Crohn's disease-linked variants of both NOD2 and ATG16L1 had less effective autophagy-mediated bacterial clearance. These findings lend further credence to the significance of altered autophagy in the pathogenesis of IBD.
Nonetheless, further research is warranted into whether autophagy actually plays a role in maintaining the integrity of the intestinal barrier in vivo; that is, whether commensal bacteria can enter the cell and are cleared by autophagy. It is also possible that autophagy proteins may be mediating functions outside of the classical autophagy pathway, which merit greater investigation.
Regulatory T cells: induction of a T cell population by specific commensal bacteria
It has been known for many years that regulatory T cells (Tregs), a T cell population with suppressive functions, are important in maintaining peripheral tolerance, especially to commensal microbes within the gastrointestinal tract. There are both natural Tregs, which develop in the thymus, and adaptive Tregs, which develop in the per-iphery from existing T cells. The intestinal environment is especially conducive toward the conversion of these adaptive Tregs [56, 57] . Tregs are able to ameliorate murine models of inflammatory bowel disease and infectious colitis [58] [59] [60] . They have multiple suppressive mechanisms, including the production of IL-10, which has a central role in inhibiting intestinal inflammation [61] .
Remarkably, two recent studies have shown the induction of Tregs and the ability to improve colitis by specific bacteria. Atarashi et al. [62 ] demonstrated the induction of colonic Tregs in germ-free mice by a mixture of commensal Clostridium species, but not by Bacteroides or Lactobacilli strains. The Tregs generated produced IL-10 and were functionally competent at suppressing effector T cells. This Treg development was not dependent on pattern recognition receptor signaling. Colonization with Clostridium XIVa and IV taxa was protective against experimental colitis caused by both DSS and oxazolone. Notably, these bacterial clusters are found in lower proportions in patients with IBD than in healthy individuals [22, 63 ] .
A second study by Round and Mazmanian [64] showed that monoassociation of germ-free mice with Bacteroides fragilis increased the percentage of IL-10-producing Foxp3 þ Treg cells with effective suppressive function in the colon. One important point is that this phenomenon required both the presence of bacterial polysaccharide A (PSA) and TLR2. Administration of purified PSA reduced the inflammation in response to the colitis-inducing chemical TNBS, even when given days after initiation of disease.
Conclusion
These discoveries illustrate a direct method by which the intestinal microbiota is able to shape the immune response and potentially trigger IBD. Genetically predisposed individuals may have alterations in their microbiota, which then disturb the normal regulatory mechanisms at the barrier that maintains tolerance to commensal organisms. Future studies should use novel technologies and methodologies to focus on elucidating the details of these interactions and how dysbiosis might be initiated.
